0001578563-24-000370.txt : 20240814 0001578563-24-000370.hdr.sgml : 20240814 20240814170451 ACCESSION NUMBER: 0001578563-24-000370 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240813 FILED AS OF DATE: 20240814 DATE AS OF CHANGE: 20240814 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Goldman Jonathan CENTRAL INDEX KEY: 0002013869 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37590 FILM NUMBER: 241209354 MAIL ADDRESS: STREET 1: 540 GAITHER ROAD STREET 2: SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Avalo Therapeutics, Inc. CENTRAL INDEX KEY: 0001534120 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 450705648 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 540 GAITHER ROAD STREET 2: SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 410-522-8707 MAIL ADDRESS: STREET 1: 540 GAITHER ROAD STREET 2: SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: Cerecor Inc. DATE OF NAME CHANGE: 20111102 4 1 primary_doc.xml PRIMARY DOCUMENT X0508 4 2024-08-13 0 0001534120 Avalo Therapeutics, Inc. AVTX 0002013869 Goldman Jonathan C/O AVALO THERAPEUTICS, INC. 540 GAITHER ROAD, SUITE 400 ROCKVILLE MD 20850 1 0 0 0 0 Stock Option (Right to Buy) 9.88 2024-08-13 4 A 0 24600 0 A 2034-08-13 Common Stock 24600 24600 D Restricted Stock Units 2024-08-13 4 A 0 9500 0 A Common Stock 9500 9500 D The stock option vests 1/3 on March 28, 2025, March 28, 2026, and March 28, 2027, subject to the Reporting Person's continued service on such vesting date. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock upon the vesting date. The RSUs vest 1/3 on March 28, 2025, March 28, 2026, and March 28, 2027, subject to the Reporting Person's continued service on such vesting date. /s/ Donald R. Reynolds, by Power of Attorney 2024-08-14